A Randomized Controlled Trial of Intranasal Dexmedetomidine
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
We designed this study to examine whether the intranasal dexmedetomidine, as a preoperative
drug, could improve the satisfaction of adult patients undergoing phacoemulsification
cataract surgery.